METTL3 and neoplasm: When METTL3 is deleted in NK cells, the expression of SHP2, a tyrosine phosphatase, is decreased, which represses the activation of the AKT and MAPK signaling pathway, thus leading to NK cells hyporesponsive to IL-15 and accelerated tumor development and shortened survival in mice 78.